[Defibrination syndrome: treatment with an antifibrinolytic drug and anticoagulants].
D000614:Aminocaproates / Q000627:therapeutic use; D000925:Anticoagulants / Q000627:therapeutic use*; D000933:Antifibrinolytic Agents / Q000627:therapeutic use*; D001778:Blood Coagulation Disorders / Q000188:drug therapy*; D001780:Blood Coagulation Tests; D002648:Child; D002951:Citrates / Q000627:therapeutic use; D006470:Hemorrhage / Q000188:drug therapy*; D006493:Heparin / Q000627:therapeutic use; D006801:Humans; D016403:Lymphoma, Large B-Cell, Diffuse / Q000150:complications*; D008297:Male; D012878:Skin Neoplasms / Q000150:complications*
D000614:Aminocaproates; D000925:Anticoagulants; D000933:Antifibrinolytic Agents; D002951:Citrates; D006493:Heparin
Sidrome da defibrinazione: terapia con un antifibrinolitico ed anticoagulanti.